Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Micro-X Ltd. ( (AU:MX1) ) has shared an update.
Micro-X Ltd. has secured a significant supply agreement with a major U.S. healthcare provider for its Rover Plus mobile radiology system, marking its first deal with a large U.S. healthcare entity. This agreement, following a successful evaluation and tender process, allows the Rover Plus to be procured by the provider’s extensive network of healthcare facilities without further evaluations, positioning Micro-X as a competitive player in the conservative global healthcare market. The deal is expected to enhance Micro-X’s market presence and operational capacity, with ongoing negotiations for additional sales opportunities.
The most recent analyst rating on (AU:MX1) stock is a Buy with a A$0.21 price target. To see the full list of analyst forecasts on Micro-X Ltd. stock, see the AU:MX1 Stock Forecast page.
More about Micro-X Ltd.
Micro-X Limited is an ASX-listed high-tech company specializing in the development and commercialization of innovative products for global health and security markets. Utilizing proprietary cold cathode, carbon nanotube emitter technology, Micro-X produces x-ray products that are smaller, lighter, and more energy-efficient, enhancing mobility and usability. The company operates a fully integrated design and production facility in Adelaide, Australia, and has a growing presence in the US market with a technical and commercial team based in Seattle. Their product portfolio includes mobile digital radiology products for healthcare, military, and veterinary applications, as well as projects with the US Department of Homeland Security and the Australian Government.
Average Trading Volume: 281,907
Technical Sentiment Signal: Sell
Current Market Cap: A$43.37M
Find detailed analytics on MX1 stock on TipRanks’ Stock Analysis page.